世界の点鼻薬市場予測2021年-2028年

◆英語タイトル:GLOBAL NASAL SPRAY MARKET FORECAST 2021-2028

Inkwood Researchが発行した調査報告書(INK21N025)◆商品コード:INK21N025
◆発行会社(リサーチ会社):Inkwood Research
◆発行日:2021年8月
◆ページ数:255
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥370,000見積依頼/購入/質問フォーム
Multi LicenseUSD3,000 ⇒換算¥444,000見積依頼/購入/質問フォーム
Enterprisewide PriceUSD4,500 ⇒換算¥666,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

本市場調査レポートでは、点鼻薬の世界市場について調査・分析し、調査範囲・手法、エグゼクティブサマリー、市場動向、主要分析、製品別(充血除去点鼻薬、ステロイド点鼻薬、塩水溶液/生理食塩水点鼻薬)分析、処方別(店頭(OTC)、処方)分析、治療別(抗ヒスタミン薬、経鼻ステロイド、抗コリン作用薬、マスト細胞阻害剤)分析、用途別(鼻閉、アレルギー性・非アレルギー性鼻炎、ワクチン、中枢神経系疾患、その他)分析、地域別分析、競争状況などの項目を掲載しています。
・調査範囲・手法
・エグゼクティブサマリー
・市場動向
・主要分析
・点鼻薬の世界市場規模:製品別(充血除去点鼻薬、ステロイド点鼻薬、塩水溶液/生理食塩水点鼻薬)
・点鼻薬の世界市場規模:処方別(店頭(OTC)、処方)
・点鼻薬の世界市場規模:治療別(抗ヒスタミン薬、経鼻ステロイド、抗コリン作用薬、マスト細胞阻害剤)
・点鼻薬の世界市場規模:用途別(鼻閉、アレルギー性・非アレルギー性鼻炎、ワクチン、中枢神経系疾患、その他)
・点鼻薬の世界市場規模:地域別
・競争状況

KEY FINDINGS
The global nasal spray market growth is anticipated to progress at a CAGR of 9.39% during the forecast period, 2021-2028. The increasing intranasal vaccines for COVID-19, growing adoption of nasal sprays due to easy administration methods, and rising acceptance in self-medication propel market growth.

MARKET INSIGHTS
Nasal sprays are used to treat allergies, sinus infections, and congestion. There is an increasing number of allergy cases in western countries. Also, as per the World Allergy Organization, more than 400 million have allergic rhinitis (AR) across the world.
The COVID-19 pandemic, due to its contagious nature, has sped up vaccination trials across the globe. The nasal route is evaluated to have significant potential for vaccination, given the organized immune systems of the nasal mucosa. Also, nasal delivery has several benefits over the traditional approaches to vaccine administration, such as ease of administration without needles. As a result, several companies are manufacturing nasal spray vaccines. In an independent clinical trial, Amcyte Pharma’s Nasitrol nasal spray was found to be effective in reducing COVID-19 infections among ICU (Intensive Care Unit) staff. Such factors facilitate growth. However, the risks associated with the overuse of nasal sprays hamper the market growth.

REGIONAL INSIGHTS
The global nasal spray market growth assessment includes the analysis of Europe, North America, Asia-Pacific, and Rest of World. North America is the dominating region in terms of revenue share, accredited to breathing problems in the region caused by chronic obstructive pulmonary disease (COPD).

COMPETITIVE INSIGHTS
The competitive rivalry in the market is characterized by companies offering unique products and thereby harboring a major share in that specific target products. GlaxoSmithKline Plc, Novartis International AG, Pfizer Inc, Johnson & Johnson, etc., are among the key companies in the market.

Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

❖ レポートの目次 ❖

TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
3. MARKET DYNAMICS
3.1. KEY DRIVERS
3.1.1. RISING ADOPTION OF NASAL SPRAYS AMONG PATIENTS
3.1.2. GROWING ACCEPTANCE OF SELF-MEDICATION
3.1.3. INCREASING INTRANASAL VACCINES FOR COVID-19
3.2. KEY RESTRAINTS
3.2.1. OVERUSE RISKS ASSOCIATED WITH NASAL SPRAYS
4. KEY ANALYTICS
4.1. IMPACT OF COVID-19 ON NASAL SPRAY MARKET
4.2. KEY MARKET TRENDS
4.3. PORTER’S FIVE FORCES ANALYSIS
4.3.1. BUYERS POWER
4.3.2. SUPPLIERS POWER
4.3.3. SUBSTITUTION
4.3.4. NEW ENTRANTS
4.3.5. INDUSTRY RIVALRY
4.4. OPPORTUNITY MATRIX
4.5. VENDOR LANDSCAPE
5. MARKET BY PRODUCT
5.1. DECONGESTION NASAL SPRAY
5.2. STEROID NASAL SPRAY
5.3. SALTWATER SOLUTION/SALINE NASAL SPRAY
6. MARKET BY PRESCRIPTION
6.1. OVER THE COUNTER
6.2. PRESCRIBED
7. MARKET BY THERAPEUTIC
7.1. ANTIHISTAMINE
7.2. NASAL STEROIDS
7.3. ANTICHOLINERGIC
7.4. MAST CELL INHIBITOR
8. MARKET BY APPLICATION
8.1. NASAL CONGESTION
8.2. ALLERGIC AND NON-ALLERGIC RHINITIS
8.3. VACCINATION
8.4. CNS DISORDERS
8.5. OTHER APPLICATIONS
9. MARKET BY END-USER
9.1. HOME CARE SETTING
9.2. ASC/CLINICS
9.3. PHARMACY
9.4. HOSPITAL
9.5. OTHER END-USERS
10. GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1. MARKET SIZE & ESTIMATES
10.1.2. KEY DRIVERS
10.1.3. KEY CHALLENGES
10.1.4. KEY PLAYERS
10.1.5. COUNTRY ANALYSIS
10.1.5.1. UNITED STATES
10.1.5.2. CANADA
10.2. EUROPE
10.2.1. MARKET SIZE & ESTIMATES
10.2.2. KEY DRIVERS
10.2.3. KEY CHALLENGES
10.2.4. KEY PLAYERS
10.2.5. COUNTRY ANALYSIS
10.2.5.1. UNITED KINGDOM
10.2.5.2. GERMANY
10.2.5.3. FRANCE
10.2.5.4. ITALY
10.2.5.5. RUSSIA
10.2.5.6. BELGIUM
10.2.5.7. POLAND
10.2.5.8. REST OF EUROPE
10.3. ASIA-PACIFIC
10.3.1. MARKET SIZE & ESTIMATES
10.3.2. KEY DRIVERS
10.3.3. KEY CHALLENGES
10.3.4. KEY PLAYERS
10.3.5. COUNTRY ANALYSIS
10.3.5.1. CHINA
10.3.5.2. JAPAN
10.3.5.3. INDIA
10.3.5.4. SOUTH KOREA
10.3.5.5. INDONESIA
10.3.5.6. THAILAND
10.3.5.7. VIETNAM
10.3.5.8. AUSTRALIA & NEW ZEALAND
10.3.5.9. REST OF ASIA-PACIFIC
10.4. REST OF THE WORLD
10.4.1. MARKET SIZE & ESTIMATES
10.4.2. KEY DRIVERS
10.4.3. KEY CHALLENGES
10.4.4. REGIONAL ANALYSIS
10.4.4.1. LATIN AMERICA
10.4.4.2. MIDDLE EAST & AFRICA
11. COMPETITIVE LANDSCAPE
11.1. KEY STRATEGIC DEVELOPMENTS
11.1.1. MERGERS & ACQUISITIONS
11.1.2. PARTNERSHIPS & AGREEMENTS
11.2. COMPANY PROFILES
11.2.1. AKORN INCORPORATED
11.2.2. ALLERGAN PLC
11.2.3. APOTEX INC
11.2.4. BHARAT BIOTECH
11.2.5. CATALENT INC
11.2.6. CIPLA LIMITED
11.2.7. GLAXOSMITHKLINE PLC
11.2.8. JOHNSON & JOHNSON
11.2.9. NOVARTIS INTERNATIONAL AG
11.2.10. PFIZER INC
11.2.11. PROCTOR & GAMBLE CO (P&G)
11.2.12. SANOTIZE RESEARCH AND DEVELOPMENT
11.2.13. SUN PHARMACEUTICALS INDUSTRIES LTD
11.2.14. TEVA PHARMACEUTICALS INDUSTRIES LTD
11.2.15. VIATRIS

LIST OF TABLES
TABLE 1: MARKET SNAPSHOT – NASAL SPRAY
TABLE 2: GLOBAL NASAL SPRAY MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 3: GLOBAL NASAL SPRAY MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 4: GLOBAL DECONGESTION NASAL SPRAY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 5: GLOBAL DECONGESTION NASAL SPRAY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 6: GLOBAL STEROID NASAL SPRAY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 7: GLOBAL STEROID NASAL SPRAY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 8: GLOBAL SALTWATER SOLUTION/SALINE NASAL SPRAY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 9: GLOBAL SALTWATER SOLUTION/SALINE NASAL SPRAY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 10: GLOBAL NASAL SPRAY MARKET, BY PRESCRIPTION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 11: GLOBAL NASAL SPRAY MARKET, BY PRESCRIPTION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 12: GLOBAL OVER THE COUNTER MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 13: GLOBAL OVER THE COUNTER MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 14: GLOBAL PRESCRIBED MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 15: GLOBAL PRESCRIBED MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 16: GLOBAL NASAL SPRAY MARKET, BY THERAPEUTIC, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 17: GLOBAL NASAL SPRAY MARKET, BY THERAPEUTIC, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 18: GLOBAL ANTIHISTAMINE MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 19: GLOBAL ANTIHISTAMINE MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 20: GLOBAL NASAL STEROIDS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION
TABLE 21: GLOBAL NASAL STEROIDS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 22: GLOBAL ANTICHOLINERGIC MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 23: GLOBAL ANTICHOLINERGIC MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 24: GLOBAL MAST CELL INHIBITOR MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 25: GLOBAL MAST CELL INHIBITOR MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 26: GLOBAL NASAL SPRAY MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 27: GLOBAL NASAL SPRAY MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 28: GLOBAL NASAL CONGESTION MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 29: GLOBAL NASAL CONGESTION MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 30: GLOBAL ALLERGIC AND NON-ALLERGIC RHINITIS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 31: GLOBAL ALLERGIC AND NON-ALLERGIC RHINITIS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 32: GLOBAL VACCINATION MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 33: GLOBAL VACCINATION MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 34: GLOBAL CNS DISORDERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 35: GLOBAL CNS DISORDERS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 36: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 37: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 38: GLOBAL NASAL SPRAY MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 39: GLOBAL NASAL SPRAY MARKET, BY END-USER, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 40: GLOBAL HOME CARE SETTING MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 41: GLOBAL HOME CARE SETTING MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 42: GLOBAL ASC/CLINICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION
TABLE 43: GLOBAL ASC/CLINICS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 44: GLOBAL PHARMACY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 45: GLOBAL PHARMACY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 46: GLOBAL HOSPITAL MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 47: GLOBAL HOSPITAL MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 48: GLOBAL OTHER END-USERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 49: GLOBAL OTHER END-USERS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 50: GLOBAL NASAL SPRAY MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 51: GLOBAL NASAL SPRAY MARKET, BY GEOGRAPHY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 52: NORTH AMERICA NASAL SPRAY MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 53: NORTH AMERICA NASAL SPRAY MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 54: KEY PLAYERS IN NORTH AMERICA NASAL SPRAY MARKET
TABLE 55: EUROPE NASAL SPRAY MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 56: EUROPE NASAL SPRAY MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 57: KEY PLAYERS IN EUROPE NASAL SPRAY MARKET
TABLE 58: ASIA-PACIFIC NASAL SPRAY MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 59: ASIA-PACIFIC NASAL SPRAY MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 60: KEY PLAYERS IN ASIA-PACIFIC NASAL SPRAY MARKET
TABLE 61: REST OF WORLD NASAL SPRAY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 62: REST OF WORLD NASAL SPRAY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 63: KEY PLAYERS IN REST OF WORLD NASAL SPRAY MARKET
TABLE 64: LIST OF MERGERS & ACQUISITIONS
TABLE 65: LIST OF PARTNERSHIPS & AGREEMENTS


LIST OF FIGURES
FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER’S FIVE FORCES ANALYSIS
FIGURE 3: OPPORTUNITY MATRIX
FIGURE 4: VENDOR LANDSCAPE
FIGURE 5: GLOBAL NASAL SPRAY MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2020
FIGURE 6: GLOBAL NASAL SPRAY MARKET, BY DECONGESTION NASAL SPRAY, 2021-2028 (IN $ MILLION)
FIGURE 7: GLOBAL NASAL SPRAY MARKET, BY STEROID NASAL SPRAY, 2021-2028 (IN $ MILLION)
FIGURE 8: GLOBAL NASAL SPRAY MARKET, BY SALTWATER SOLUTION/SALINE NASAL SPRAY, 2021-2028 (IN $ MILLION)
FIGURE 9: GLOBAL NASAL SPRAY MARKET, GROWTH POTENTIAL, BY PRESCRIPTION, IN 2020
FIGURE 10: GLOBAL NASAL SPRAY MARKET, BY OVER THE COUNTER, 2021-2028 (IN $ MILLION)
FIGURE 11: GLOBAL NASAL SPRAY MARKET, BY PRESCRIBED, 2021-2028 (IN $ MILLION)
FIGURE 12: GLOBAL NASAL SPRAY MARKET, GROWTH POTENTIAL, BY THERAPEUTIC, IN 2020
FIGURE 13: GLOBAL NASAL SPRAY MARKET, BY ANTIHISTAMINE, 2021-2028 (IN $ MILLION)
FIGURE 14: GLOBAL NASAL SPRAY MARKET, BY NASAL STEROIDS, 2021-2028 (IN $ MILLION)
FIGURE 15: GLOBAL NASAL SPRAY MARKET, BY ANTICHOLINERGIC, 2021-2028 (IN $ MILLION)
FIGURE 16: GLOBAL NASAL SPRAY MARKET, BY MAST CELL INHIBITOR, 2021-2028 (IN $ MILLION)
FIGURE 17: GLOBAL NASAL SPRAY MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2020
FIGURE 18: GLOBAL NASAL SPRAY MARKET, BY NASAL CONGESTION, 2021-2028 (IN $ MILLION)
FIGURE 19: GLOBAL NASAL SPRAY MARKET, BY ALLERGIC AND NON-ALLERGIC RHINITIS, 2021-2028 (IN $ MILLION)
FIGURE 20: GLOBAL NASAL SPRAY MARKET, BY VACCINATION, 2021-2028 (IN $ MILLION)
FIGURE 21: GLOBAL NASAL SPRAY MARKET, BY CNS DISORDERS, 2021-2028 (IN $ MILLION)
FIGURE 22: GLOBAL NASAL SPRAY MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)
FIGURE 23: GLOBAL NASAL SPRAY MARKET, GROWTH POTENTIAL, BY END-USER, IN 2020
FIGURE 24: GLOBAL NASAL SPRAY MARKET, BY HOME CARE SETTING, 2021-2028 (IN $ MILLION)
FIGURE 25: GLOBAL NASAL SPRAY MARKET, BY ASC/CLINICS, 2021-2028 (IN $ MILLION)
FIGURE 26: GLOBAL NASAL SPRAY MARKET, BY PHARMACY, 2021-2028 (IN $ MILLION)
FIGURE 27: GLOBAL NASAL SPRAY MARKET, BY HOSPITAL, 2021-2028 (IN $ MILLION)
FIGURE 28: GLOBAL NASAL SPRAY MARKET, BY OTHER END-USERS, 2021-2028 (IN $ MILLION)
FIGURE 29: GLOBAL NASAL SPRAY MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
FIGURE 30: NORTH AMERICA NASAL SPRAY MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
FIGURE 31: UNITED STATES NASAL MARKET, 2021-2028 (IN $ MILLION)
FIGURE 32: CANADA NASAL SPRAY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 33: EUROPE NASAL SPRAY MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
FIGURE 34: UNITED KINGDOM NASAL SPRAY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 35: GERMANY NASAL SPRAY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 36: FRANCE NASAL SPRAY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 37: ITALY NASAL SPRAY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 38: RUSSIA NASAL SPRAY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 39: BELGIUM NASAL SPRAY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 40: POLAND NASAL SPRAY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 41: REST OF EUROPE NASAL SPRAY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 42: ASIA-PACIFIC NASAL SPRAY MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
FIGURE 43: CHINA NASAL SPRAY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 44: JAPAN NASAL SPRAY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 45: INDIA NASAL SPRAY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 46: SOUTH KOREA NASAL SPRAY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 47: INDONESIA NASAL SPRAY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 48: THAILAND NASAL SPRAY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 49: VIETNAM NASAL SPRAY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 50: AUSTRALIA AND NEW ZEALAND NASAL SPRAY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 51: REST OF ASIA-PACIFIC NASAL SPRAY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 52: REST OF THE WORLD NASAL SPRAY MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
FIGURE 53: LATIN AMERICA NASAL SPRAY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 54: MIDDLE EAST & AFRICA NASAL SPRAY MARKET, 2021-2028 (IN $ MILLION)


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の点鼻薬市場予測2021年-2028年(GLOBAL NASAL SPRAY MARKET FORECAST 2021-2028)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆